Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

178 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Does medicalization of life imperil health? Expanding indications for diagnosis and treatment of chronic "disease".
Fairman KA, Curtiss FR. Fairman KA, et al. Among authors: curtiss fr. J Manag Care Pharm. 2011 Jul-Aug;17(6):469-80. doi: 10.18553/jmcp.2011.17.6.469. J Manag Care Pharm. 2011. PMID: 21787033 No abstract available.
VBID, the PPACA, and FREEE medications: Did politics trump the evidence about cost sharing?
Fairman KA, Curtiss FR. Fairman KA, et al. Among authors: curtiss fr. J Manag Care Pharm. 2012 Mar;18(2):146-55. doi: 10.18553/jmcp.2012.18.2.146. J Manag Care Pharm. 2012. PMID: 22380473 No abstract available.
How do seniors respond to 100% cost-sharing for prescription drugs? Quality of the evidence underlying opinions about the Medicare Part D coverage gap.
Fairman KA, Curtiss FR. Fairman KA, et al. Among authors: curtiss fr. J Manag Care Pharm. 2011 Jun;17(5):382-92. doi: 10.18553/jmcp.2011.17.5.382. J Manag Care Pharm. 2011. PMID: 21657807
Protecting patients from adverse drug events: propoxyphene, PIMs, and drugs to avoid in older adults.
Curtiss FR, Fairman KA. Curtiss FR, et al. J Manag Care Pharm. 2011 Jan-Feb;17(1):60-9. doi: 10.18553/jmcp.2011.17.1.60. J Manag Care Pharm. 2011. PMID: 21204591 No abstract available.
No TREATment with darbepoetin dosed to hemoglobin 13 grams per deciliter in type 2 diabetes with pre-dialysis chronic kidney disease--safety warnings for erythropoiesis-stimulating agents.
Curtiss FR, Fairman KA. Curtiss FR, et al. J Manag Care Pharm. 2009 Nov-Dec;15(9):759-65. doi: 10.18553/jmcp.2009.15.9.759. J Manag Care Pharm. 2009. PMID: 19954267 No abstract available.
Forecasting cholesterol management--end of the statin gold rush?
Crownover BK, Curtiss FR. Crownover BK, et al. Among authors: curtiss fr. J Manag Care Pharm. 2006 Jul-Aug;12(6):479-85. doi: 10.18553/jmcp.2006.12.6.479. J Manag Care Pharm. 2006. PMID: 16925456 Review. No abstract available.
What is the future of thiazolidinediones (TZDs) after market introduction of inhaled insulin?
Curtiss FR. Curtiss FR. J Manag Care Pharm. 2006 Mar;12(2):169-72. doi: 10.18553/jmcp.2006.12.2.169. J Manag Care Pharm. 2006. PMID: 16515377 No abstract available.
Asthma disease management--evidence-based medicine must be dynamic.
Curtiss FR. Curtiss FR. J Manag Care Pharm. 2006 Jan-Feb;12(1):80-2. doi: 10.18553/jmcp.2006.12.1.80. J Manag Care Pharm. 2006. PMID: 16420113 No abstract available.
COX-2 inhibitors: little or no GI protection, increased risk of cardiovascular events, high cost, and other class-less effects.
Curtiss FR. Curtiss FR. J Manag Care Pharm. 2005 Sep;11(7):590-3. doi: 10.18553/jmcp.2005.11.7.590. J Manag Care Pharm. 2005. PMID: 16137219 No abstract available.
Best value for money in triptans.
Curtiss FR. Curtiss FR. J Manag Care Pharm. 2005 Jun;11(5):419-21. doi: 10.18553/jmcp.2005.11.5.419. J Manag Care Pharm. 2005. PMID: 15934803 No abstract available.
178 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback